sangamo biosciences inc (SGMO:NASDAQ GS)

Executive Profile*

Background*

Mr. David G. Ichikawa has been the Senior Vice President of Business Development of Sangamo Biosciences Inc. since December 2004. Mr. Ichikawa is responsible for all licensing and business development activities for Sangamo Biosciences Inc. Prior to joining Sangamo, from February 2002 to September 2004, Mr. Ichikawa served as the Chief Business Officer for Sagres Discovery, where he was responsible for corporate strategy and business development activities. While at ... Sagres he negotiated a major collaboration with Boehringer Ingelheim, the strategic acquisition of MemRx Corporation and played a critical role in the acquisition of Sagres by Chiron Corporation. He has more than 20 years of industry experience with both pharmaceutical and biotechnology companies in various commercial areas. Prior to Sagres Discovery, from 1994 to February 2002, he held several positions with Chiron Corporation including Vice President, R&D Business Development and Finance. Mr. Ichikawa earned an M.B.A. degree from the University of California at Berkeley and a B.S. degree from the University of California at Davis.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
SGMO:US	$8.18 USD	+0.19

COMPETITOR COMPENSATION